Project overview
Idiopathic pulmonary fibrosis (IPF) is a life-threatening condition of the lungs where tissue becomes thickened, stiff, and scarred, limiting the amount of oxygen getting into the blood. The aim of this project is to provide effective targeted therapies for sufferers to reduce symptoms of this devastating disease and improve their quality of life as well as to identify biomarkers for IPF patients.
Staff
Lead researcher
Collaborating research institutes, centres and groups
Research outputs
Xiaofan Liu,
Fang Ni,
Fangfang Jiang,
Yan Jiang,
Cheng Song,
Mingli Yuan,
Zhaowu Tao,
Mingxin Ye,
Junjie Xu,
Ying Wang,
Qiong Qian,
Yi Hu,
, 2022
, Respiratory Research
, 23
Type: article
Yilu Zhou,
Ayse Ertay,
Philip Williamson,
Xinhui Tang,
Jialian Wang,
, 2022
, Frontiers in Plant Science
, 13
Type: article
Michael Eyres,
Elizabeth R. Davies,
Aurelie Fabre,
Aiman Alzetani,
Sanjay Jogai,
Sophie V. Fletcher,
Gayle Marshall,
Emily Offer,
&
, 2022
, Cell Reports
, 40 (7)
Type: article
Yuan Yuan,
Guoqiang Qiao,
Jiajiao Zhou,
Yilu Zhou,
Yali Li,
Xia Li,
Zhenglin Jiang,
, 2022
, Genes and Diseases
Type: article
Pseudohypoxic HIF pathway activation dysregulates collagen structure-function in human lung fibrosis
Christopher J. Brereton,
Liudi Yao,
Elizabeth R. Davies,
Yilu Zhou,
Milica Vukmirovic,
Robert A. Ridley,
Orestis G. Andriotis,
Franco Conforti,
Lennart Brewitz,
Soran Mohammed,
Timothy Wallis,
Aiman Alzetani,
Sophie V. Fletcher,
Philipp J. Thurner,
Aurelie Fabre,
Naftali Kaminski,
Luca Richeldi,
Atul Bhaskar,
Christopher J. Schofield,
&
, 2022
, eLife
, 11
DOI: 10.7554/eLife.69348
Type: article